Insect Cell Recombinant Protein Production via Stress Induction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing recombinant proteins in cellular agriculture face challenges in scalability, cost-effectiveness, and ethical concerns, particularly in the production of cultured meat and dairy products, where traditional systems rely on fetal bovine serum and bacterial systems lack post-translational modifications.

Innovation Solution

Genetically modifying insect populations, such as Drosophila, to produce target compounds like growth factors by applying specific stressors, which enables the production of biologically active recombinant proteins with post-translational modifications, scalable, and cost-effective, using a serum-free growth media.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional bacterial systems are used for recombinant protein production, then production speed is fast, but post-translational modifications are lacking

Engineering Contradiction:
Improvepost-translational modificationsVSAvoidproduction speed
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent changes the biological system parameter from bacteria to insect cells (specifically Drosophila S2 cells), which possess the cellular machinery for post-translational modifications while maintaining rapid growth and production capabilities. This parameter change resolves the contradiction by finding a middle ground system that offers both modifications and speed.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If fetal bovine serum is used in growth media, then cell growth is supported, but ethical concerns and cost issues arise

Engineering Contradiction:
Improvecell growth supportVSAvoidethical concerns and cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent extracts and eliminates the fetal bovine serum component from the growth media, replacing it with serum-free alternatives. This removal resolves the ethical and cost issues while maintaining cell growth support through alternative nutrients and growth factors.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs cost-effective, ethically acceptable serum-free media components that can be produced more sustainably, replacing the expensive and ethically problematic fetal bovine serum while maintaining adequate cell growth support.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Productivity

If insect populations are genetically modified and stressed to produce target compounds, then production efficiency increases, but process complexity increases

Engineering Contradiction:
Improveproduction efficiencyVSAvoidprocess complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent employs the insect cells' own biological stress response mechanisms to drive protein production. By applying controlled stressors (temperature shifts, chemical inducers), the system leverages the cells' endogenous heat shock protein pathways and other stress-induced mechanisms to automatically increase target protein expression without requiring complex external intervention.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for efficient and cost-effective production of recombinant proteins with post-translational modifications, addressing ethical concerns and scalability issues, enabling the development of serum-free growth media for cultured meat and dairy products.

Implementation Method 1

applying a first dosage of a first stressor to the population of insects to trigger production of the target compound by the population of insects

Methodology Applied
Scientific EffectStress response:

Data Source

PatentUS20240268362A1Method for producing recombinant proteins in insects
Publication Date: 2024.08.15 FUTURE FIELDS CELLULAR AGRI & RES LTD
  • US20240268362A1 patent drawing
  • US20240268362A1 patent drawing
  • US20240268362A1 patent drawing

AI summary

One variation of a method for producing a target compound includes: during an initial period, genetically modifying a population of insects to produce a target compound; during a growth period succeeding the initial period, cultivating the population of insects; during a treatment period succeeding the growth period, applying a dosage of a stressor to the population of insects, the stressor configured to trigger production of the target compound; in response to a proportion of the target compound within the population of insects exceeding a threshold proportion, harvesting the population of insects; homogenizing the population of insects to form a blend comprising the proportion of the target compound and a second proportion of a set of secondary components; and separating the proportion of the target compound from the second proportion of the set of secondary components for extraction of the proportion of the target compound from the blend.